Literature DB >> 19001285

T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman.

Shahina Daar, Anil V Pathare, Rajeev Jain, Shoaib Al Zadjali, Dudley J Pennell.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19001285      PMCID： PMC2625422          DOI： 10.3324/haematol.13845

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

2.  Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

Authors:  N G Bellenger; M I Burgess; S G Ray; A Lahiri; A J Coats; J G Cleland; D J Pennell
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

Review 3.  Evaluation of iron overload.

Authors:  Peter-D Jensen
Journal:  Br J Haematol       Date:  2004-03       Impact factor: 6.998

4.  Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.

Authors:  M A Tanner; R Galanello; C Dessi; M A Westwood; G C Smith; S V Nair; L J Anderson; J M Walker; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2006       Impact factor: 5.364

5.  A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.

Authors:  M A Tanner; R Galanello; C Dessi; G C Smith; M A Westwood; A Agus; M Roughton; R Assomull; S V Nair; J M Walker; D J Pennell
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

6.  Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

Authors:  Caterina Borgna-Pignatti; Maria Domenica Cappellini; Piero De Stefano; Giovanni Carlo Del Vecchio; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Maria Antonietta Romeo; Huaqing Zhao; Avital Cnaan
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

7.  Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.

Authors:  Annita Kolnagou; Charalambos Economides; Eleni Eracleous; George J Kontoghiorghes
Journal:  Hemoglobin       Date:  2006       Impact factor: 0.849

8.  Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with beta-thalassemia major.

Authors:  Kang-Hsi Wu; Jan-Gowth Chang; Yung-Jen Ho; Shu-Fen Wu; Ching-Tien Peng
Journal:  Hemoglobin       Date:  2006       Impact factor: 0.849

9.  Survival in medically treated patients with homozygous beta-thalassemia.

Authors:  N F Olivieri; D G Nathan; J H MacMillan; A S Wayne; P P Liu; A McGee; M Martin; G Koren; A R Cohen
Journal:  N Engl J Med       Date:  1994-09-01       Impact factor: 91.245

10.  Onset of cardiac iron loading in pediatric patients with thalassemia major.

Authors:  John C Wood; Raffaella Origa; Annalisa Agus; Gildo Matta; Thomas D Coates; Renzo Galanello
Journal:  Haematologica       Date:  2008-04-15       Impact factor: 9.941
View more
  6 in total

1.  Understanding Iron Metabolism: Lessons from Transfusion-dependent Thalassemia.

Authors:  Murtadha Al-Khabori; Shahina Daar
Journal:  Oman Med J       Date:  2018-01

2.  Rapid iron loading in heart and liver in a patient with transfusion dependent thalassaemia after brief poor compliance with iron chelation therapy.

Authors:  Shahina Daar; Saeed Ahmed; Vasili Berdoukas
Journal:  Sultan Qaboos Univ Med J       Date:  2010-11-14

3.  On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.

Authors:  D J Pennell; J P Carpenter; M Roughton; Zi Cabantchik
Journal:  J Cardiovasc Magn Reson       Date:  2011-09-12       Impact factor: 5.364

4.  The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.

Authors:  Narumol Chaosuwannakit; Pattarapong Makarawate; Chinnadol Wanitpongpun
Journal:  Tomography       Date:  2021-04-18

5.  Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.

Authors:  Anil Pathare; Ali Taher; Shahina Daar
Journal:  Ann Hematol       Date:  2009-10-02       Impact factor: 3.673

6.  Evaluation of Glutathione-S-Transferase P1 Polymorphism and its Relation to Bone Mineral Density in Egyptian Children and Adolescents with Beta-Thalassemia Major.

Authors:  Seham M Ragab; Eman A Badr; Ahmed S Ibrahim
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.